研究报告 |
|
|
|
|
S100A9参与介导具核梭杆菌促结肠癌细胞的增殖与迁移的作用 * |
户丽君1,段亮2,黄逸云1,林璐1,黄茂1,陈露1,彭棋1,胡琴1,张彦1,周兰1,**() |
1 重庆医科大学检验医学院 临床检验诊断学教育部重点实验室 重庆 400016 2 重庆医科大学附属第二医院 重庆 400010 |
|
S100A9 Is Involved in Fusobacterium nucleatum-Induced Proliferation and Migration of Colon Cancer HCT116 and SW480 Cells |
HU Li-jun1,DUAN Liang2,HUANG Yi-yun1,LIN Lu1,HUANG Mao1,CHEN Lu1,PENG Qi1,HU Qin1,ZHANG Yan1,ZHOU Lan1,**() |
1 Key Laboratory of Laboratory Medical Diagnostics of Ministry of Education, Chongqing Medical University, Chongqing 400016, China 2 Department of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China |
引用本文:
户丽君,段亮,黄逸云,林璐,黄茂,陈露,彭棋,胡琴,张彦,周兰. S100A9参与介导具核梭杆菌促结肠癌细胞的增殖与迁移的作用 *[J]. 中国生物工程杂志, 2020, 40(1-2): 84-91.
HU Li-jun,DUAN Liang,HUANG Yi-yun,LIN Lu,HUANG Mao,CHEN Lu,PENG Qi,HU Qin,ZHANG Yan,ZHOU Lan. S100A9 Is Involved in Fusobacterium nucleatum-Induced Proliferation and Migration of Colon Cancer HCT116 and SW480 Cells. China Biotechnology, 2020, 40(1-2): 84-91.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.1905001
或
https://manu60.magtech.com.cn/biotech/CN/Y2020/V40/I1-2/84
|
[1] |
Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin, 2013,63(1):11-30.
|
[2] |
Cartwright T H . Treatment decisions after diagnosis of metastatic colorectal cancer. Clin Colorectal Cancer, 2012,11(3):155-66.
|
[3] |
Brenner H, Kloor M, Pox C P . Colorectal cancer. Lancet, 2014,383(9927):1490-1502.
|
[4] |
Castellarin M I, Warren R L, Freeman J D , et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res, 2012,22(2):299-306.
|
[5] |
Brennan C A, Garrett W S, Garrett W S . Gut microbiota, inflammation, and colorectal cancer. Annu Rev Microbiol, 2016,70(1):395-411.
|
[6] |
Yang N Y, Zhang Q, Li J L , et al. Progression of periodontal inflammation in adolescents is associated with increased number of Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythensis, and Fusobacterium nucleatum. Int J Paediatr Dent, 2014,24(3):226-233.
|
[7] |
Fujii R, Saito Y, Tokura Y , et al. Characterization of bacterial flora in persistent apical periodontitis lesions. Oral Microbiol Immunol, 2009,24(6):502-505.
|
[8] |
Ahmed Z, Bansal S K, Dhillon S . Pyogenic liver abscess caused by Fusobacterium in a 21-year-old immunocompetent male. World J Gastroenterol, 2015,21(12):3731-3735.
|
[9] |
Yarden-Bilavsky H, Raveh E, Livni G , et al. Fusobacterium necrophorum mastoiditis in children - emerging pathogen in an old disease. Int J Pediatr Otorhinolaryngol, 2013,77(1):92-96.
|
[10] |
Flanagan L, Schmid J, Ebert M , et al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis, 2014,33(8):1381-1390.
|
[11] |
Rubinstein M R, Wang X, Liu W , et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe, 2013,14(2):195-206.
|
[12] |
Strupat K, Rogniaux H, Van Dorsselaer A , et al. Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 are confirmed by electrospray ionization-mass analysis. J Am Soc Mass Spectrom, 2000,11(9):780-788.
|
[13] |
Shu P, Zhao L, Wagn J , et al. Association between serum levels of S100A8/S100A9 and clinical features of colorectal cancer patients. Journal of Central South University, 2016,41(6):553-559.
|
[14] |
Duan L, Wu R, Ye L , et al. S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway. PLoS One, 2013,8(4):e62092.
|
[15] |
Rhee K J, Wu S, Wu X , et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun, 2009,77(4):1708-1718.
|
[16] |
Concetti J, Wilson C L . NFKB1 and cancer: friend or foe. Cells, 2018,7(9):133.
|
[17] |
Mira-Pascual L, Cabrera-Rubio R, Ocon S , et al. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol, 2015,50(2):167-179.
|
[18] |
Abed J, Emgård J E, Zamir G , et al. Fap2 Mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe, 2016,20(2):215-225.
|
[19] |
Mima K, Nishihara R, Qian Z R , et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut, 2016,65(12):1973-1980.
|
[20] |
Li Y Y, Ge Q X, Cao J , et al. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients. World J Gastroenterol, 2016,22(11):3227-3233.
|
[21] |
Yang Y, Weng W, Peng J , et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating TLR4 signaling to NFκB, upregulating expression of microRNA-21. Gastroenterology, 2017,152(4):851-866
|
[22] |
Rumman N, Sultan M, El-Chammas K , et al. Calprotectin in cystic fibrosis. BMC Pediatr, 2014,14(1):133.
|
[23] |
Poullis A, Foster R, Mendall M A , et al. Emerging role of calprotectin in gastroenterology. J Gastroenterol Hepatol, 2003,18(7):756-762.
|
[24] |
Nilsen T, Sunde K, Larsson A . A new turbidimetric immunoassay for serum calprotectin for fully automatized clinical analysers. J Inflamm (Lond), 2015,12(1):45.
|
[25] |
Srikrishna G . S100A8 and S100A9: new insights into their roles in malignancy. J Innate Immun, 2012,4(1):31-40.
|
[26] |
Bassorgun C, Unal B, Erin N , et al. S100A8 and S100A9 Positive cells in colorectal carcinoma: clinicopathological analysis. Gastroenterol Res Pract, 2014,2014, doi: 10.1155/2014/943175.
doi: 10.1155/2014/943175
|
[27] |
Kostic A D, Chun E, Robertson L , et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host & Microbe, 2013,14(2):207-215.
|
[28] |
Milward M R, Chapple I L, Carter K , et al. Micronutrient modulation of NF-kappaB in oral keratinocytes exposed to periodontal bacteria. Innate Immun, 2013,19(2):140-151.
|
[29] |
Ali N, Chandrakesan P, Nguyen C B , et al. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases. Oncotarget, 2015,6(24):20327-20344.
|
[30] |
Pollock C B, Rodriguez O, Martin P L , et al. Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation. PPAR Res, 2010,2010571783.
|
[31] |
Shi C, Yang Y, Xia Y , et al. Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer. Gut, 2016,65(9):1470-1481.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|